1. Home
  2. MOMO vs ZYME Comparison

MOMO vs ZYME Comparison

Compare MOMO & ZYME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MOMO
  • ZYME
  • Stock Information
  • Founded
  • MOMO 2011
  • ZYME 2003
  • Country
  • MOMO China
  • ZYME United States
  • Employees
  • MOMO N/A
  • ZYME N/A
  • Industry
  • MOMO Computer Software: Prepackaged Software
  • ZYME Biotechnology: Pharmaceutical Preparations
  • Sector
  • MOMO Technology
  • ZYME Health Care
  • Exchange
  • MOMO Nasdaq
  • ZYME Nasdaq
  • Market Cap
  • MOMO 909.4M
  • ZYME 867.6M
  • IPO Year
  • MOMO 2014
  • ZYME 2017
  • Fundamental
  • Price
  • MOMO $8.53
  • ZYME $13.57
  • Analyst Decision
  • MOMO Buy
  • ZYME Buy
  • Analyst Count
  • MOMO 2
  • ZYME 7
  • Target Price
  • MOMO $10.00
  • ZYME $19.50
  • AVG Volume (30 Days)
  • MOMO 1.5M
  • ZYME 495.3K
  • Earning Date
  • MOMO 09-02-2025
  • ZYME 07-31-2025
  • Dividend Yield
  • MOMO 3.51%
  • ZYME N/A
  • EPS Growth
  • MOMO N/A
  • ZYME N/A
  • EPS
  • MOMO 1.06
  • ZYME N/A
  • Revenue
  • MOMO $1,450,201,337.00
  • ZYME $93,384,000.00
  • Revenue This Year
  • MOMO $0.97
  • ZYME $44.71
  • Revenue Next Year
  • MOMO $4.25
  • ZYME $34.57
  • P/E Ratio
  • MOMO $8.29
  • ZYME N/A
  • Revenue Growth
  • MOMO N/A
  • ZYME 85.05
  • 52 Week Low
  • MOMO $5.12
  • ZYME $8.83
  • 52 Week High
  • MOMO $8.94
  • ZYME $17.70
  • Technical
  • Relative Strength Index (RSI)
  • MOMO 62.12
  • ZYME 62.00
  • Support Level
  • MOMO $8.25
  • ZYME $12.75
  • Resistance Level
  • MOMO $8.94
  • ZYME $13.14
  • Average True Range (ATR)
  • MOMO 0.26
  • ZYME 0.43
  • MACD
  • MOMO -0.07
  • ZYME 0.04
  • Stochastic Oscillator
  • MOMO 37.14
  • ZYME 97.61

About MOMO Hello Group Inc.

Hello Group Inc provides mobile-based social networking services. It enables users to establish and expand social relationships based on location and interests. Its platform includes the Momo mobile application and a variety of related features, functionalities, tools, and services that it provides to users, customers, and platform partners. The company derives its revenue from live video services, value-added services, mobile marketing services, mobile games, and other services. It operates in three segments: Momo's service lines, Tantan's service lines, and QOOL's service lines, out of which Momo's service lines segment derives the majority of revenue.

About ZYME Zymeworks Inc.

Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. The company is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.

Share on Social Networks: